Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NCT05398471
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. This data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future rheumatoid arthritis patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Patient has been diagnosed with rheumatoid arthritis
- Patient has self-identified as planning to enroll in an interventional clinical trial
- Patient is 18 years old
- ECOG score of 4
- Patient is pregnant
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient remains in clinical trial to completion 12 months Patient decides to enroll in clinical trial 3 Months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States